The new capabilities of the Wave RPD System are expected to drive future growth at Celerus beyond IHC and into rapid molecular assays. Feasibility has been demonstrated for same-day fluorescent in situ hybridization (FISH) and same-day chromogenic in situ hybridization (CISH) of common DNA targets such as Her2/neu.

On-board heating technology and sophisticated thermal control software have been added to the Wave RPD System, allowing for deparaffinization and antigen retrieval. These steps, along with the patented Wave motion technology, deliver Rapid IHC results in one hour. This improves turnaround time is one third of other IHC instruments taking up to three or more hours.

Jason Lusk, VP of business development, said: “Pathologists will have the ability to see IHC results that can aid in a differential diagnosis faster than ever before. For a patient waiting on laboratory tests, a possible cancer diagnosis and subsequent treatment options, this reduced turnaround time is significant. The Wave RPD System will deliver the fastest standardized, high-quality IHC results available.”

Dave Gross, CEO, said: “We’re extremely proud to present the Wave RPD, our second generation Rapid IHC system. The Wave RPD System is unparalleled in the industry and this annual meeting of leading US and Canadian pathologists is the ideal venue for its introduction.”